跳至主要内容
临床试验/ACTRN12611000610932
ACTRN12611000610932尚未招募2 期

Therapeutic effect of saffron compared to a placebo on cognitive function and depression in definitive multiple sclerosis patients

Tehran University of medical science0 个研究点目标入组 60 人开始时间: 2011年6月14日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 55 Years(—)
性别
All

入选标准

  • Definitive diagnosed MS with MC-donald 2010 criteria
  • 3 of 5 memory domain involvement(BRB-N test)
  • Do not use any treatment for memory function up to 3 month before intervention
  • Ability to do the test and fill the questionnaire him/herself

排除标准

  • Other cause of cognitive impairment other than MS
  • MS attack in previous month before intervention
  • Severe depression according to Beck-2 in the beginning of the intervention
  • Alcohol or drug abuse among the study

研究者

发起方
Tehran University of medical science

相似试验

Therapeutic effect of saffron on cognitive function ... | 临床试验